{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:27:03Z","timestamp":1761488823391},"reference-count":27,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>The majority of human infections associated with H7 influenza viruses have resulted in ocular and not respiratory disease. While oseltamivir has been prescribed to individuals presenting with conjunctivitis following H7 virus exposure, it is unknown if oseltamivir inhibits virus replication in ocular tissue. We demonstrate that H7 viruses possess sensitivity to neuraminidase inhibitors and that administration of oseltamivir before ocular virus challenge in mice inhibits H7N7 and H7N3 virus replication in ocular and respiratory tissues.<\/jats:p>","DOI":"10.1128\/aac.06101-11","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T05:21:18Z","timestamp":1323753678000},"page":"1616-1618","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["Oseltamivir Inhibits H7 Influenza Virus Replication in Mice Inoculated by the Ocular Route"],"prefix":"10.1128","volume":"56","author":[{"given":"Jessica A.","family":"Belser","sequence":"first","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Sleeman","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa B.","family":"Pearce","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline M.","family":"Katz","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa V.","family":"Gubareva","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence M.","family":"Tumpey","sequence":"additional","affiliation":[{"name":"Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007050050695"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801259105"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1506.090072"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01235-07"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00535-09"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq018"},{"key":"e_1_3_2_8_2","unstructured":"CDC. 20 September 2010 posting date. Guidelines and recommendations: prevention strategies for seasonal influenza in healthcare settings. Centers for Disease Control and Prevention Atlanta GA."},{"key":"e_1_3_2_9_2","unstructured":"CDC. 14 January 2006 posting date. Interim guidance for protection of persons involved in U.S. avian influenza outbreak disease control and eradication activities. Centers for Disease Control and Prevention Atlanta GA."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2334-10-141","article-title":"Assessing the role of contact tracing in a suspected H7N2 influenza A outbreak in humans in Wales","volume":"10","author":"Eames KT","year":"2010","unstructured":"EamesKT. 2010. Assessing the role of contact tracing in a suspected H7N2 influenza A outbreak in humans in Wales. BMC Infect. Dis. 10:141.","journal-title":"BMC Infect. Dis"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308352100"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)11433-8"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/314440"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/viro.1995.1489","article-title":"Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid","volume":"212","author":"Gubareva LV","year":"1995","unstructured":"GubarevaLV PennCR WebsterRG. 1995. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 212:323\u2013330.","journal-title":"Virology"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.82256-0"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00970-07"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15589-X"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3201\/eid1501.070660","article-title":"Personal protective equipment and risk for avian influenza (H7N3)","volume":"15","author":"Morgan O","year":"2009","unstructured":"MorganO. 2009. Personal protective equipment and risk for avian influenza (H7N3). Emerg. Infect. Dis. 15:59\u201362.","journal-title":"Emerg. Infect. Dis"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00581-10"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00555-08"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060204"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01739-09"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3201\/eid1610.091412","article-title":"Effectiveness of personal protective equipment and oseltamivir prophylaxis during avian influenza A (H7N7) epidemic, the Netherlands, 2003","volume":"16","author":"te Beest DE","year":"2010","unstructured":"te BeestDE van BovenM BosME StegemanA KoopmansMP. 2010. Effectiveness of personal protective equipment and oseltamivir prophylaxis during avian influenza A (H7N7) epidemic, the Netherlands, 2003. Emerg. Infect. Dis. 16:1562\u20131568.","journal-title":"Emerg. Infect. Dis"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1654(200001\/02)10:1<45::AID-RMV265>3.0.CO;2-R"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"13849","DOI":"10.1073\/pnas.212519699","article-title":"Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus","volume":"99","author":"Tumpey TM","year":"2002","unstructured":"TumpeyTM. 2002. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. U. S. A. 99:13849\u201313854.","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1012.040961"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.7.1473"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/432008"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.06101-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.06101-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:09:44Z","timestamp":1645481384000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.06101-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1128\/AAC.06101-11"],"URL":"https:\/\/doi.org\/10.1128\/aac.06101-11","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"2011-11-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-12-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-02-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}